Skip to main content
OpenTrials
Completed

NCT Number: NCT00774540

Acute Pain and Inflammation After Surgery

The purpose of this study is

1. to observe acute pain after surgery and measure the natural course of inflammatory mediators 2. study pain relieving effects and local anti-inflammatory effects of systemically administered ketorolac

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Oslo University Hospital, Division of Emergencies and Critical Care

Oslo, 0242, Norway

About this study

Randomizized controlled trial

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Day case surgical patients above 18 years old
  • Non pregnant

Exclusion criteria

-

Treatment and study plan

1 Ketorolac intraarticular

Drug

Ketorolac intraarticular 5 mg

Other names: Ketorolac, Saline

Placebo

Drug

Saline

Primary outcomes

  1. Pain relief local anti-flammatory effects

    Time frame: 2 h

Secondary outcomes

  1. Rescue analgesic consumption

    Time frame: 2 h

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Official study title

Acute Pain and Role of Ketolorac in Inflammatory Mediators After Knee Arthroscopy Evaluated by Microdialysis

Acronym: Knemikro01

Important dates

Study start
2008
Primary completion
2014
Study completion
2014
First posted
Oct 17, 2008
Registry last updated
Apr 23, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.